Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
GHK-Cu vs GHK-Cu (Scalp)
An educational, source-based comparison of GHK-Cu and GHK-Cu (Scalp) — how each peptide works, what it's researched for, and what to know before going deeper.
A naturally occurring tripeptide (Glycyl-L-Histidyl-L-Lysine) that forms a complex with copper(II) ions. Research indicates it modulates ~4,000 human genes, downregulating those associated with inflammation and tissue breakdown while upregulating genes tied to collagen synthesis, antioxidant defense, and stem cell activation.
- Collagen and elastin synthesis
- Wound healing
- Hair follicle stimulation
- Skin barrier and antioxidant capacity
- Anti-glycation in dermal fibroblasts
- • Topical formulations have decades of cosmetic safety data; injectable use is less studied.
- • Copper sensitivity is rare but possible.
- • Compounded injectable GHK-Cu is not FDA-approved.
Topical GHK-Cu applied to the scalp has been studied for its ability to enlarge hair follicles, prolong the anagen growth phase, and improve perifollicular vascularization through copper-dependent gene modulation.
- Follicle size and anagen phase
- Perifollicular angiogenesis
- Post-procedure scalp recovery (microneedling, transplant)
- • Topical use has a long cosmetic safety record.
- • Not a replacement for evidence-based therapies like minoxidil or finasteride.
Trial-evidence rating
Educational grade reflecting how many peer-reviewed studies and FDA actions we cite for each peptide. Not a clinical recommendation.
Two cited studies; independent replication needed.
Early-stage research; conclusions are tentative.
Study-by-study comparison
| Peptide | Study | Source | Year | Summary |
|---|---|---|---|---|
| GHK-Cu | GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration | BioMed Research International | 2015 | Comprehensive review of GHK-Cu's gene modulation and tissue remodeling effects. |
| GHK-Cu | Resetting skin genome back to health | Cosmetics & Toiletries | 2013 | Documented gene expression changes restoring older skin patterns toward youthful profiles. |
| GHK-Cu (Scalp) | Copper peptides and hair growth | Journal of the American Academy of Dermatology | 2007 | Reported follicular stimulation and improved hair density in early trials. |
Side-effect & safety grid
- Topical formulations have decades of cosmetic safety data; injectable use is less studied.
- Copper sensitivity is rare but possible.
- Compounded injectable GHK-Cu is not FDA-approved.
- Topical use has a long cosmetic safety record.
- Not a replacement for evidence-based therapies like minoxidil or finasteride.
Educational summary of considerations reported in research literature — not a complete list of adverse events. Discuss with a licensed clinician before any use.
GHK-Cu vs GHK-Cu (Scalp) — Key differences
- Class: GHK-Cu is classified as Skin · Regeneration, while GHK-Cu (Scalp) is Hair · Follicle Health.
- Primary research focus: GHK-Cu — collagen and elastin synthesis; GHK-Cu (Scalp) — follicle size and anagen phase.
- Tag: Skin · Anti-aging vs Hair.